ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Other Current Assets

Current assets not reported separately, such as prepaid expenses.

No reported Other Current Assets figures are available to summarize.

Other Current Assets history

Currency unavailable · from the balance sheet

No Other Current Assets data reported for this period type.

Other Current Assets vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Other Current Assets for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SLNSilence Therapeutics plcMar 2026$10.56M USD-35.7%—9.2%
STOKStoke Therapeutics, Inc.Mar 2026$6.88M USD+34.6%+14.1%1.6%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$4.16M USD-89.2%-17.0%1.7%
WVEWave Life Sciences Ltd.Mar 2026$3.46M USD-49.5%+13.4%0.6%
PRMEPrime Medicine, Inc.Mar 2026$2.39M USD-85.5%+144.9%0.8%
BNTCBenitec Biopharma Inc.Mar 2026$1.25M USD+195.5%+275.5%0.7%
MGTXMeiraGTx Holdings plcMar 2026$670K USD+10.6%-2.9%0.3%
RNAAtrium Therapeutics, Inc.Mar 2026$138K USD——0.0%
PRQRProQR Therapeutics N.V.Mar 2026€0 EUR——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-35.7%+13.8%0.7%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.